Where does Araxes Pharma LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Araxes Pharma LLC ranks #7,112 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Araxes Pharma LLC hold?

Araxes Pharma LLC holds 46 US utility patents granted between 2016 and 2025, spanning 10 technology areas.

What is Araxes Pharma LLC's Innovation Score?

Araxes Pharma LLC has an Innovation Score of 41.3 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Araxes Pharma LLC focus on?

Araxes Pharma LLC's top technology area is C07D (Heterocyclic Compounds) with 41 patents, ranking #200 of 3,165 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Araxes Pharma LLC's patent grant rate increasing or decreasing?

Araxes Pharma LLC's recent grant velocity is +39% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Araxes Pharma LLC's patents?

Araxes Pharma LLC's patents average 27.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Araxes Pharma LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Araxes Pharma LLC

USPTO PatentsView assignee record - 46 granted patents across 10 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Araxes ranks #7,112 of 49,997 tracked US assignees by granted-patent volume, with 46 patents across 10 technology areas.

#7,112
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.3/100): 27.0
avg claims per patent: +39%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7112 · US Corporation #7,112 · 46 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 46 grants
UPPER-Q #7,112/49,997
PHOTO-FINISH Aerie Pharmaceuticals
CPC-FOCUS C07D · 10 areas
INNOV-PAR 41.3/100
CLAIMS-DENSE 27.0 claims/avg
TYPE-USCORP US Corporation
VEL-UP +39% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aerie Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Araxes’s 41.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.3 pts (32%) Velocity 1.8 pts (4%) Breadth 11.2 pts (27%) Claim depth 15.0 pts (36%)

Qualcomm Incorporated · highest

85
Aesynt Incorporated · near

41
Araxes Pharma · this assignee

41
Draeger Medical… · near

41
Laser Technology · near

41
Pruitt Tool & Supply · near

41
3D Lighting… · lowest

7

What this shows Araxes's Innovation Score is 41.3/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Araxes?

Each dot is one of Araxes’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Araxes’s own 27.0 claims/patent is ABOVE the 18.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Araxes vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Araxes's grants concentrate

Araxes Pharma LLC is a focused PatentsView assignee: 10 CPC subclasses with 89.1% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2020 (11 grants) versus a trough of 1 in 2016. By volume, Araxes sits between Ariel Scientific Innovations Ltd. and Binj Laboratories, Inc..

Araxes's three-year grant acceleration

From 2019–2021 to 2022–2024, Araxes Pharma LLC moved from 26 to 7 grants (0.27x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Ariel Scientific…

46
Atonarp

46
Aerie Pharmaceuti…

46
Anton Paar

46
Artisan Vehicle S…

46
Auspex Pharmaceut…

46
Avive Solutions

46
Binj Laboratories

46
Araxes Pharma ◀

46

What this shows Araxes holds 46 patents at rank #7,115, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Araxes

By rank, the assignees closest to #7,115 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Araxes's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Araxes, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Araxes ranks #200 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Pruitt Tool & Supply Co. 41 Draeger Medical Systems, Inc. 41 Aesynt Incorporated 41 Laser Technology, Inc. 41

Araxes's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Araxes Pharma LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	2.2%
2017	3	6.5%
2018	6	13.0%
2019	8	17.4%
2020	11	23.9%
2021	7	15.2%
2022	4	8.7%
2023	1	2.2%
2024	2	4.3%
2025partial year	3	6.5%

Which technologies does Araxes Pharma LLC patent most?

C07D - Heterocyclic Compounds 41

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 38

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 15

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 5

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C12Y - Enzymes 2

C07C - Acyclic OR Carbocyclic Compounds 1

C11D - Detergent COMPOSITIONS; USE OF Single Substances AS DETERGENTS; Soap OR SOAP-MAKING; Resin SOAPS; Recovery OF Glycerol 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Araxes Pharma LLC's patent record in context - here's where to go next.

Araxes Pharma LLC's lead technology class is C07D (Heterocyclic Compounds), 89.1% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #7,112 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Araxes Pharma LLC against Ariel Scientific Innovations Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.